Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Reinhardt

Showing results (81-90 of 236) with videos related to

Pageof 24
Sort By:
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
Plos One|May 21, 2015
Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle ProgressionJorge Boucas, Christian Fritz, Anna Schmitt, et al.
Vaccines|October 26, 2021
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant RecipientsMonika Lindemann, Vesna Klisanin, Laura Thümmler, et al.
Scientific Reports|June 13, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesCarmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, et al.
Nature Communications|September 18, 2020
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityNiklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
Transplantation and Cellular Therapy|October 13, 2025
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in RemissionJacob Pyka, Judith Metzdorf, Christian Reicherts, et al.
Frontiers in Immunology|December 21, 2023
Mouse models of diffuse large B cell lymphomaAreya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Cancer Discovery|February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCFelix Dietlein, Lisa Thelen, Mladen Jokic, et al.
European Journal of Haematology|September 1, 2022
Luspatercept, a two-edged sword in beta-thalassemia-associated paravertebral extramedullary hematopoietic masses (EHMs)Ferras Alashkar, Hannes Klump, Cara Paulina Lange, et al.
Frontiers in Immunology|April 6, 2023
Time series clustering of T cell subsets dissects heterogeneity in immune reconstitution and clinical outcomes among MUD-HCT patients receiving ATG or PTCySaskia Leserer, Theresa Graf, Martina Franke, et al.
Pageof 24

Showing results (81-90 of 236) with videos related to

Sort By:
Pageof 24
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
Plos One|May 21, 2015
Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle ProgressionJorge Boucas, Christian Fritz, Anna Schmitt, et al.
Vaccines|October 26, 2021
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant RecipientsMonika Lindemann, Vesna Klisanin, Laura Thümmler, et al.
Scientific Reports|June 13, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesCarmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, et al.
Nature Communications|September 18, 2020
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityNiklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
Transplantation and Cellular Therapy|October 13, 2025
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in RemissionJacob Pyka, Judith Metzdorf, Christian Reicherts, et al.
Frontiers in Immunology|December 21, 2023
Mouse models of diffuse large B cell lymphomaAreya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Cancer Discovery|February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCFelix Dietlein, Lisa Thelen, Mladen Jokic, et al.
European Journal of Haematology|September 1, 2022
Luspatercept, a two-edged sword in beta-thalassemia-associated paravertebral extramedullary hematopoietic masses (EHMs)Ferras Alashkar, Hannes Klump, Cara Paulina Lange, et al.
Frontiers in Immunology|April 6, 2023
Time series clustering of T cell subsets dissects heterogeneity in immune reconstitution and clinical outcomes among MUD-HCT patients receiving ATG or PTCySaskia Leserer, Theresa Graf, Martina Franke, et al.
Pageof 24